Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control
Studying Whooping cough
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Hospital Clinico Universitario de Santiago
- Intervention
- PCR(diagnostic_test)
- Enrollment
- 784 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
Collaborators
Translational Research In Airway Diseases Group (TRIAD) · CIBER of Respiratory Diseases CIBERES · Complexo Hospitalario Universitario de A Coruña · Hospital de Galdakao · Hospital Universitario Doctor Peset · Hospital San Pedro de Alcantara · Hospital Universitario Marqués de Valdecilla · Hospital Universitario Vall d´Hebron · Universitat Autonoma de Barcelona · Universidade de Santiago de Compostela · Consortium for Biomedical Research in Epidemiology and Public Health · Hospital Universitario Virgen del Rocio · Fundación de Investigación Biomédica - Hospital Universitario de La Princesa · University Hospital Virgen de las Nieves · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Germans Trias i Pujol Hospital · Hospital of Navarra · Hospital Universitario de Jerez de la Frontera · Hospital El Bierzo · Hospital Clinico Universitario San Cecilio · Hospital Donostia · Hospital Universitario Central de Asturias · Hospital Universitario de la Ribera · Hospital Costa del Sol · Hospital General Universitario Dr. Balmis · Hospital de Sagunto · Hospital Lluis Alcanyís de Xàtiva · Hospital Universitario Lucus Augusti · Hospital del Mar · Hospital Universitario Virgen de la Arrixaca · Hospital Clinic of Barcelona
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06286007 on ClinicalTrials.govOther trials for Whooping cough
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06827470Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella PertussisDalhousie University
- RECRUITINGPHASE4NCT0680352410-year Follow-up After a Single Dose Acellular Pertussis VaccinationMahidol University
- ACTIVE NOT RECRUITINGPHASE3NCT06798831Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in AdultsBioNet-Asia Co., Ltd.
- ACTIVE NOT RECRUITINGNCT06888076Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant WomenBioNet-Asia Co., Ltd.
- RECRUITINGPHASE4NCT06903221A Phase 4, Randomised Vaccination Study in Healthy Adults to Investigate the Effects of Acellular Pertussis Vaccine on Colonisation with Bordetella Pertussis Using Controlled Human InfectionDimitri Diavatopoulos
- RECRUITINGNANCT05897879Impact of Bacterial Expression and Immune Response in the Severity of PertussisInstitut Pasteur
- RECRUITINGNANCT05847322Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 WeeksUniversity of Southampton
- ACTIVE NOT RECRUITINGPHASE4NCT05264662Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant WomenFarzanah Laher